Strattera and Combivent drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Strattera (atomoxetine hydrochloride) and Combivent (albuterol sulfate; ipratropium bromide). Common drug interactions include chronic kidney disease among females and chest pain among males.

The phase IV clinical study analyzes what interactions people have when they take Strattera and Combivent. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,324 Strattera users. Check the latest studies of Strattera.

What is Combivent?

Combivent has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in asthma. eHealthMe is studying from 35,341 Combivent users. Check the latest studies of Combivent.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

18 people who take Strattera and Combivent together, and have interactions are studied.

Strattera and Combivent drug interactions.

What are the common drug interactions of Strattera and Combivent, by gender? *:

female:

Chronic kidney disease
Death
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Weight decreased
Fluid retention (an abnormal accumulation of fluid in the blood)
Intracranial aneurysm (bulging, weak area in the wall of a cranial artery)
Lung neoplasm malignant (cancer tumour of lung)
Nodule (a growth of abnormal tissue)
Abdominal pain upper
Abnormal behaviour

male:

Chest pain
Dizziness
Genital disorder male (diseases of male genital tract)
Hyperhidrosis (abnormally increased sweating)
Mitral valve incompetence (inefficient heart valve)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
Renal impairment (severely reduced kidney function)
Ventricular hypertrophy (enlargement of ventricles (lower chambers) in the heart)
Dysuria (painful or difficult urination)

What are the common drug interactions of Strattera and Combivent, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Abdominal pain upper
Abnormal behaviour
Aggression
Chest pain
Intentional self-injury
Irritability
Mood swings (an extreme or rapid change in mood)
Somnolence (a state of near-sleep, a strong desire for sleep)
Suicidal ideation
Weight increased

20-29:

Dehydration (dryness resulting from the removal of water)
Dyspnoea (difficult or laboured respiration)
Dysuria (painful or difficult urination)
Fatigue (feeling of tiredness)

30-39:

n/a

40-49:

Chronic kidney disease
Death

50-59:

Weight decreased
Arthralgia (joint pain)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Renal impairment (severely reduced kidney function)

60+:

Breast cancer
Chronic kidney disease
Oliguria (not enough urine)
Oral pruritus (itching in mouth)
Pain in extremity
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Tinnitus (a ringing in the ears)
Cough
Dizziness
Dry mouth

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 33.33%
Pain: 6 people, 33.33%
Stress And Anxiety: 5 people, 27.78%
Hypersensitivity: 5 people, 27.78%
Fibromyalgia (a long-term condition which causes pain all over the body): 5 people, 27.78%
Muscle Spasms (muscle contraction): 5 people, 27.78%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 22.22%
High Blood Cholesterol: 4 people, 22.22%
Bipolar Disorder (mood disorder): 4 people, 22.22%
Depression: 4 people, 22.22%

* Approximation only. Some reports may have incomplete information.

Do you take Strattera and Combivent?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously